Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Amarantus Bioscience Holdings Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

18 Apr 2015 Reuters Investment Profile 12 $20.00

ValuEngine Industry Report for Medical Services(AMBS)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

16 Apr 2015 ValuEngine, Inc. 10 $49.00

ValuEngine Rating and Forecast Report for AMBS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

13 Apr 2015 ValuEngine, Inc. 10 $25.00

Amarantus Bioscience Holdings, Inc. (AMBS) - Financial Analysis Review

Amarantus Bioscience Holdings, Inc. (AMBS) - Financial Analysis Review Summary Amarantus BioScience has acquired rights to tw...

03 Feb 2015 GlobalData 46 $125.00

ValuEngine Rating and Forecast Report for AMBS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

02 Feb 2015 ValuEngine, Inc. 11 $25.00

ValuEngine Rating and Forecast Report for AMBS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

26 Jan 2015 ValuEngine, Inc. 11 $25.00

ValuEngine Rating and Forecast Report for AMBS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

12 Jan 2015 ValuEngine, Inc. 11 $25.00

ValuEngine Rating and Forecast Report for AMBS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

05 Jan 2015 ValuEngine, Inc. 11 $25.00

AMARANTUS BIOSCIENCE – EXPANDING INTO REGENERATIVE MEDICINE

Amarantus entered into an option agreement with Lonza to acquire its engineered skin substitute (ESS) platform for the treatm...

25 Nov 2014 Edison Investment Research 2 $10.00

Amarantus Bioscience Holdings, Inc. (AMBS) - Financial Analysis Review

Amarantus Bioscience Holdings, Inc. (AMBS) - Financial Analysis Review Summary Amarantus BioScience has acquired rights to tw...

03 Nov 2014 GlobalData 44 $125.00